Hyderabad based pharmaceutical majors blamed for increasing drug resistance
With possible far-reaching consequences for the pharmaceutical industry in India, a report from a European agency campaigning for the environment has blamed manufactures in Hyderabad for growing antibiotic resistance in the world. Titled ‘ Superbugs in the Supply Chain’ , the report by London-based Changing Markets Foundation aims to show how effluents from pharma majors, including Aurobindo, Hetero and Mylan based in Hyderabad, besides drug-producing units from other parts of the country, are polluting the environment with drugs that in turn are driving drug resistance at a global scale. The report claims findings of antibiotic-resistant bacteria in effluent samples tested at 14 sites in and around Hyderabad in addition to sample testing in New Delhi, Chennai and Vishakhapatnam. According to the report, sample testing outside one of Aurobindo’s production units in Polepally, about 80 km from Hyderabad, showed 70 percent of E.coli bacterial colonies in the samples were resi...